Table 1 Malaria screening in Dolisie
Age group | CSI Dimébéko n (%) [95% CI] | CSI Moupépé n (%) [95% CI] | Total n (%) [95% CI] | ||||||
|---|---|---|---|---|---|---|---|---|---|
Total screened | RDT positive | TF positive | Total screened | RDT positive | TF positive | Total screened | RDT positive | TF Positive | |
All patients | 491 | 129 (26.3) [22.4–30.4] | 103 (21.0) [17.5–24.8] | 503 | 194 (38.6) [34.3–43.0] | 163 (32.4) [28.3–36.7] | 994 | 323 (32.5) [29.6–35.5] | 266 (26.8) [24.0–29.6] |
 < 5 yr | 191 | 27 (14.1) [9.5–19.9] | 20 (10.5) [6.5–15.7] | 188 | 38 (20.2) [14.7–26.7] | 28 (14.9) [10.1–20.8] | 379 | 65 (17.2) [13.5–21.3] | 48 (12.7) [9.5–16.4] |
5– < 10 yr | 118 | 44 (37.3) [28.6–46.7] | 37 (31.4) [23.1–40.5] | 133 | 72 (54.1) [45.3–62.8] | 61 (45.9) [37.2–54.7] | 251 | 116 (46.2) [39.9–52.6] | 98 (39.0) [33.0–45.4] |
10–14 yr | 50 | 25 (50.0) [35.5–64.5] | 19 (38.0) [24.7–52.8] | 60 | 43 (71.7) [58.6–82.5] | 40 (66.7) [53.3–78.3] | 110 | 68 (61.8) [52.1–70.9] | 59 (53.6) [43.9–63.2] |
 ≥ 15 yr | 132 | 33 (25.0) [17.9–33.3] | 27 (20.5) [13.9–28.3] | 122 | 41 (33.6) [25.3–42.7] | 34 (27.9) [20.1–36.7] | 254 | 74 (29.1) [23.6–35.1] | 61 (24.0) [18.9–29.8] |